| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of CLCN2 mRNA | affects expression | 17562736
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CLCN2 mRNA | affects expression | 16483693
|
| D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of CLCN2 mRNA | increases expression | 16644059
|
| D002712 |
Chlorides |
CLCN2 protein affects the transport of Chlorides | affects transport | 15213059
|
| D002712 |
Chlorides |
lubiprostone promotes the reaction [CLCN2 protein affects the transport of Chlorides] | affects transport|increases reaction | 15213059
|
| C014347 |
decitabine |
decitabine results in increased expression of CLCN2 mRNA | increases expression | 15251184
|
| C014347 |
decitabine |
[Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of CLCN2 mRNA | affects cotreatment|increases expression | 15251184
|
| D005419 |
Flavonoids |
Flavonoids results in increased expression of CLCN2 mRNA | increases expression | 18035473
|
| C506401 |
lubiprostone |
lubiprostone promotes the reaction [CLCN2 protein affects the transport of Chlorides] | affects transport|increases reaction | 15213059
|
| C506401 |
lubiprostone |
lubiprostone results in increased activity of CLCN2 protein | increases activity | 15213059
|
| C506401 |
lubiprostone |
CLCN2 protein affects the susceptibility to lubiprostone | affects response to substance | 18805957
|
| C506401 |
lubiprostone |
CLCN2 protein binds to and results in increased activity of lubiprostone | affects binding|increases activity | 18805957
|
| D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of CLCN2 mRNA] | affects reaction|decreases expression | 19482888
|
| D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of CLCN2 mRNA | decreases expression | 19482888
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CLCN2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of CLCN2 mRNA | affects cotreatment|increases expression | 15251184
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
9.10 | 6195326 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.10 | 15322242 11752688 14514962 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.80 | 18287403 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.30 | 18653653 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
18.74 | 17620307 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
18.74 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.74 | 16835633 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.11 | 10982225 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.35 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.35 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.08 | 18320071 19208741 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.08 | 20435547 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.99 | 16050911 16097048 18705752 16124888 16192424 3786805 10355542 15673190 16011737 16227642 15700767 15721981 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.67 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.67 | 18788625 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
4.67 | 17173139 20007298 20935162 1701930 6705139 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.63 | 19215824 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18850075 18670907 16120746 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.67 | 10977129 |
| MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.47 | 4080065 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.95 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 8697196 15340226 16354765 12621046 15668235 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.36 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.49 | 18249437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.39 | 11287661 19923254 10663392 2444490 18713872 14550746 19739265 11529661 12153990 15619225 17906064 12540782 10915739 12594235 12705907 19164858 12392966 11743745 18071297 11739529 14986274 19420014 10774834 16081117 19416960 19085960 16781746 11421492 12958197 16485898 14725611 16177239 17522070 16227642 16109766 15968718 11461765 19370779 11834606 16393943 17562736 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
6.39 | 3786805 16177239 6884620 19085960 10092053 2869522 7120509 21278145 19336974 7440962 3732212 10915739 15027814 15968718 7179309 9327722 16227642 17522070 11566570 15998439 6623471 4309450 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.39 | 20420201 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.36 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.19 | 1851702 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
7.11 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.11 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 15322242 16714409 18230668 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.38 | 19294695 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 9294722 10568697 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.32 | 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.14 | 11558140 3922381 |
| MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.97 | 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
marker/mechanism |
|
| |
| MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.69 | 6401628 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.47 | 7750514 |
| MESH:D004829 |
Epilepsy, Generalized |
marker/mechanism |
|
| |
| OMIM:607682 |
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9 |
marker/mechanism |
|
| |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.26 | 3659116 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
8.25 | 12795759 16239168 15959796 61145 16045604 19224547 12631006 17595544 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.25 | 19236843 20131406 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
9.33 | 18705752 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.33 | 20067830 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.94 | 16983495 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.60 | 19215824 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 11294989 10048152 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.63 | 20558911 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
| MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.79 | 19900420 19110552 |
| MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
15.69 | 16109766 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.69 | 18467677 19176532 19772884 16221962 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.69 | 16120746 15340226 12621046 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 18606429 15340226 16354765 8697196 16959395 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.84 | 16870215 |
| MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.77 | 16899240 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.34 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.96 | 18670907 18850075 |
| MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.30 | 15338365 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
3.31 | 17581917 |
| MESH:D007249 |
Inflammation |
|
Flavonoids |
5.27 | 17296493 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.27 | 12200463 12878042 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.74 | 16306350 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.29 | 12587719 15629191 |
| MESH:D007938 |
Leukemia |
|
decitabine |
3.15 | 19235587 18980019 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.17 | 19117987 17236224 18454857 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.40 | 18206229 18704418 19387464 19010910 18460780 17679729 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.73 | 18055864 |
| MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.93 | 17157831 17334410 16943688 17174718 21278145 16221502 16239168 11903743 11408273 |
| MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.93 | 21047994 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.48 | 12632512 17640975 15123356 17698563 15362042 18006644 15996030 12609069 17766677 12445421 17761835 15052691 17631135 18429990 18187930 18418968 12741479 17976157 15730626 15057751 15673190 18166357 16192424 16116963 12586293 14620537 12632514 16033810 18339082 15959796 17708605 16027843 12958196 10355542 12649538 11481614 18395914 18395095 15931870 18481824 18251166 15650968 15338365 12666154 18412020 18317297 16638106 14716833 17805973 18705752 17922224 15925388 16015684 17900296 17557913 16011737 12898905 18054572 15818738 15370692 17481882 13678700 18376398 14724832 12546737 17565644 17869086 18156304 18472332 14716496 17714472 18263696 16136751 20821823 14748882 15876570 18472094 18279442 18277467 17525996 18210741 14512876 12445418 17823541 16248980 12389079 17944888 17721639 12667390 15893842 16097048 18420326 18205269 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.48 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.48 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.71 | 12969438 12587719 19460945 16611625 19014921 11587558 16610002 19784758 |
| MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.71 | 15720792 15830285 16964402 16246199 17285989 |
| MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.71 | 19363144 |
| MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.38 | 15123358 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.95 | 17185352 16871587 |
| MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
9.95 | 16899240 14706259 |
| MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
11.16 | 19294768 |
| MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
11.16 | 21047994 19812893 19073162 19482888 15975961 8742319 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.16 | 16377806 15890375 20007298 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.16 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
10.40 | 15583823 12014681 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
10.40 | 6150874 17172636 18308698 1399818 2563599 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.40 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
3.54 | 19470736 |
| MESH:D008545 |
Melanoma |
|
decitabine |
2.26 | 17785578 16505122 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.78 | 19513568 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.46 | 18172295 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.72 | 16239165 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.47 | 18608210 19157545 16882708 19010910 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.20 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.08 | 16411023 |
| MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.71 | 17484760 |
| MESH:D020190 |
Myoclonic Epilepsy, Juvenile |
marker/mechanism |
|
| |
| MESH:D009369 |
Neoplasms |
|
decitabine |
5.28 | 17925555 19116145 19470736 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.28 | 17405874 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.01 | 18514411 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
| MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.60 | 17016548 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.69 | 19259094 19331143 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.53 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.57 | 19294695 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.57 | 16965848 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.77 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11222880 11896295 11399792 11118676 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.94 | 17616702 |
| MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.76 | 12752131 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.46 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.59 | 19155313 |
| MESH:D012640 |
Seizures |
|
Phenobarbital |
2.80 | 3137016 11442880 16876388 4039156 |
| MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.06 | 6407741 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.11 | 16192470 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.75 | 17967635 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
7.75 | 1399818 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.78 | 17616700 19087683 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.16 | 10982225 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.18 | 17785578 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |